Vimarsana
Biggest News Aggregation in the World

Page 16 - Topline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Topline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Topline Today - Breaking & Trending Today

Majorel Group Luxembourg S.A. : Majorel reports strong topline growth of +11% for Q1 2023 - Vimarsana News

Majorel Group Luxembourg S.A. : Majorel reports strong topline growth of +11% for Q1 2023

EQS-Ad-hoc: Majorel Group Luxembourg S.A. / Key word: Quarter Results/Quarter Results Majorel Group Luxembourg S.A. : Majorel reports strong topline growth of +11% for Q1 2023 03-May-2023 /... | May 3, 2023

Vifor International AG (CSL Vifor): Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis - Vimarsana News

Vifor International AG (CSL Vifor): Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis

The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secondary and topline exploratory endpoints trended favorably for sparsentan Treatment

Travere Therapeutics Announces Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis - Vimarsana News

Travere Therapeutics Announces Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis

The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secondary and topline exploratory endpoints trended favorably for sparsentan Treatment with... | May 1, 2023

Travere Therapeutics : Corporate Overview – May 2023 - Vimarsana News

Travere Therapeutics : Corporate Overview – May 2023

Topline Data from the Two-Year Endpoints in the Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis May 1, 2023 ... | May 1, 2023

Ebro Foods : The rice business in the spotlight - Vimarsana News

Ebro Foods : The rice business in the spotlight

EARNINGS/SALES RELEASESIn the Q1-2023, Ebro Foods once again demonstrated its resilience in the face of the current macroeconomic environment. The company’s topline was largely bolstered by its... | April 28, 2023